|Mining the “Gold Rush” of Immunotherapy Clinical Trials|
As the number of immunotherapy clinical trials grows, so do the obstacles and challenges – including the need to ensure meaningful results.
Entering A New Era of Immunotherapy
The first approval of a chimeric antigen receptor T-cell therapy marks a shift in the future of the immunotherapy field.
|The Year in Drug Approvals|
The excitement over immunotherapy for cancer treatment shows no signs of waning, with several agents approved by the U.S. Food and Drug Administration this year.
|The Immunotherapy Pipeline|
Dozens of immunotherapeutic agents are under investigation for the treatment of malignant and non-malignant hematologic conditions.
All good stuff...
13 October 2017 (Friday) - ASH Update
The American Society of Hematology sent me a few snippets today: